Research Article
Synergistic Effects of Cabozantinib and EGFR-Specific CAR-NK-92 Cells in Renal Cell Carcinoma
Figure 4
Specific cytotoxicity exhibited by EGFR-specific CAR-NK-92 cells against EGFR+ target cells. The cytotoxic activity of CAR-NK-92 and Ctrl-NK-92 cells against EGFRā or EGFR+ cancer cells was determined using a 4āh lactate dehydrogenase (LDH) release assay in a dose-dependent manner. ; ; . ns: not significant.